Detalhe da pesquisa
1.
Enasidenib vs conventional care in older patients with late-stage mutant-IDH2 relapsed/refractory AML: a randomized phase 3 trial.
Blood
; 141(2): 156-167, 2023 01 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35714312
2.
Omidubicel vs standard myeloablative umbilical cord blood transplantation: results of a phase 3 randomized study.
Blood
; 138(16): 1429-1440, 2021 10 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-34157093
3.
Comparison of myeloid neoplasms with nonclassic 3q26.2/MECOM versus classic inv(3)/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profiles, and molecular mechanisms of MECOM activation.
Genes Chromosomes Cancer
; 61(2): 71-80, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34668265
4.
Gilteritinib clinical activity in relapsed/refractory FLT3 mutated acute myeloid leukemia previously treated with FLT3 inhibitors.
Am J Hematol
; 97(3): 322-328, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34981560
5.
Impact of race on outcomes in intermediate-risk acute myeloid leukemia.
Cancer Causes Control
; 32(7): 705-712, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-33837498
6.
Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia.
Blood
; 133(1): 7-17, 2019 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30361262
7.
Identification and targeting of novel CDK9 complexes in acute myeloid leukemia.
Blood
; 133(11): 1171-1185, 2019 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30587525
8.
Pentostatin, Cyclophosphamide, and Rituximab Followed by Alemtuzumab for Relapsed or Refractory Chronic Lymphocytic Leukemia: A Phase 2 Trial of the ECOG-Acrin Cancer Research Group (E2903).
Acta Haematol
; 142(4): 224-232, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31336367
9.
Results of a phase 1 study of quizartinib as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic stem cell transplant.
Am J Hematol
; 93(2): 222-231, 2018 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29090473
10.
EBV-negative aggressive NK-cell leukemia/lymphoma: a clinical and pathological study from a single institution.
Mod Pathol
; 30(8): 1100-1115, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28548121
11.
NCCN Guidelines Insights: Acute Lymphoblastic Leukemia, Version 1.2017.
J Natl Compr Canc Netw
; 15(9): 1091-1102, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28874594
12.
Myelodysplastic Syndromes, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(1): 60-87, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28040720
13.
Activity of SL-401, a targeted therapy directed to interleukin-3 receptor, in blastic plasmacytoid dendritic cell neoplasm patients.
Blood
; 124(3): 385-92, 2014 Jul 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-24859366
14.
Acute Lymphoblastic Leukemia, Version 2.2015.
J Natl Compr Canc Netw
; 13(10): 1240-79, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-26483064
15.
Myelodysplastic syndromes, version 2.2015.
J Natl Compr Canc Netw
; 13(3): 261-72, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25736003
16.
F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma.
Br J Haematol
; 165(6): 793-800, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24628515
17.
The impact of symptom burden on patient quality of life in chronic myeloid leukemia.
Oncology
; 87(3): 133-47, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-25012261
18.
Timing of initial antibiotic treatment for febrile neutropenia in the emergency department: the need for evidence-based guidelines.
J Natl Compr Canc Netw
; 12(11): 1569-73, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25361804
19.
Myelodysplastic syndromes: clinical practice guidelines in oncology.
J Natl Compr Canc Netw
; 11(7): 838-74, 2013 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-23847220
20.
Aspacytarabine for the treatment of patients with AML unfit for intensive chemotherapy: a phase 2 study.
Blood Adv
; 7(24): 7494-7500, 2023 12 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37903324